96 related articles for article (PubMed ID: 32145682)
1. MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma.
Tesser-Gamba F; Paolillo AT; Del Giúdice Paniago M; Petrilli AS; Seixas Alves MT; Garcia Filho RJ; Toledo SRC
Ann Diagn Pathol; 2020 Jun; 46():151482. PubMed ID: 32145682
[TBL] [Abstract][Full Text] [Related]
2. MAPK7 and MAP2K4 as prognostic markers in osteosarcoma.
Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Filho RJ; Juliano Y; Toledo SR
Hum Pathol; 2012 Jul; 43(7):994-1002. PubMed ID: 22154052
[TBL] [Abstract][Full Text] [Related]
3. MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
Tesser-Gamba F; Lopes LJ; Petrilli AS; Toledo SR
Mol Carcinog; 2016 Nov; 55(11):1700-1713. PubMed ID: 26460937
[TBL] [Abstract][Full Text] [Related]
4. MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7.
Dong X; Lv B; Li Y; Cheng Q; Su C; Yin G
Arch Biochem Biophys; 2017 Sep; 630():47-53. PubMed ID: 28734729
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase 7 promotes cell proliferation, migration and invasion in SOSP-M human osteosarcoma cell line.
Huang Y; Yao J; Zhu B; Zhang J; Sun T
Tumori; 2017 Sep; 103(5):483-488. PubMed ID: 26350187
[TBL] [Abstract][Full Text] [Related]
6. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7.
Hou Y; Feng H; Jiao J; Qian L; Sun B; Chen P; Li Q; Liang Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2065-2071. PubMed ID: 31126193
[No Abstract] [Full Text] [Related]
8. MicroRNA-187 suppresses the proliferation migration and invasion of human osteosarcoma cells by targeting MAPK7.
Liu M; Wu L; Cai C; Liu L; Xu Y
J BUON; 2020; 25(1):472-478. PubMed ID: 32277671
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
10. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.
Asnafi AA; Behzad MM; Ghanavat M; Shahjahani M; Saki N
Exp Mol Pathol; 2019 Feb; 106():63-77. PubMed ID: 30528563
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
12. Rare coding variants in MAPK7 predispose to adolescent idiopathic scoliosis.
Gao W; Chen C; Zhou T; Yang S; Gao B; Zhou H; Lian C; Wu Z; Qiu X; Yang X; Alattar E; Liu W; Su D; Sun S; Chen Y; Cheung KMC; Song Y; Luk KKD; Chan D; Sham PC; Xing C; Khor CC; Liu G; Yang J; Deng Y; Hao D; Huang D; Li QZ; Xu C; Su P
Hum Mutat; 2017 Nov; 38(11):1500-1510. PubMed ID: 28714182
[TBL] [Abstract][Full Text] [Related]
13. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Yang J; Wang ZG; Cai HQ; Li YC; Xu YL
Asian Pac J Cancer Prev; 2013; 14(8):4595-8. PubMed ID: 24083708
[TBL] [Abstract][Full Text] [Related]
14. Identification of De Novo JAK2 and MAPK7 Mutations Related to Autism Spectrum Disorder Using Whole-Exome Sequencing in a Chinese Child and Adolescent Trio-Based Sample.
Jiao J; Zhang M; Yang P; Huang Y; Hu X; Cai J; Yang C; Situ M; Zhang H; Fu L; Guo K; Huang Y
J Mol Neurosci; 2020 Feb; 70(2):219-229. PubMed ID: 31838722
[TBL] [Abstract][Full Text] [Related]
15. Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy.
Li JZ; Tian ZQ; Jiang SN; Feng T
Genet Mol Res; 2014 Apr; 13(2):3186-92. PubMed ID: 24841650
[TBL] [Abstract][Full Text] [Related]
16. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.
van Dartel M; Cornelissen PW; Redeker S; Tarkkanen M; Knuutila S; Hogendoorn PC; Westerveld A; Gomes I; Bras J; Hulsebos TJ
Cancer Genet Cytogenet; 2002 Dec; 139(2):91-6. PubMed ID: 12550767
[TBL] [Abstract][Full Text] [Related]
17. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
[TBL] [Abstract][Full Text] [Related]
18. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in miRNA processing genes and their role in osteosarcoma risk.
Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Martin-Guerrero I; Pombar-Gomez M; Zalacain-Diez M; Patiño-Garcia A; Lopez-Lopez E; Garcia-Orad A
Pediatr Blood Cancer; 2015 May; 62(5):766-9. PubMed ID: 25663449
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]